COSCIENS Biopharma Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CSCI research report →
About the company
COSCIENS Biopharma Inc. is a specialized biopharmaceutical company dedicated to the global development and commercialization of innovative therapeutic and diagnostic products. Its operations extend across Canada, Switzerland, Ireland, Denmark, Germany, the United States, and other international territories.
- CEO
- Anna Elizabeth Biehn
- IPO
- 1996
- Employees
- 40
- HQ
- Toronto, ON, CA
Price Chart
- Market Cap
- $8.57M
- P/E
- -0.50
- P/S
- 0.35
- P/B
- 0.18
- EV/EBITDA
- 0.04
- Div Yield
- 0.00%
- Gross Margin
- 37.96%
- Op Margin
- -96.00%
- Net Margin
- -92.11%
- ROE
- -92.88%
- ROIC
- -43.69%
- Revenue
- $13.78M · 92.96%
- Net Income
- $-15,309,000 · -339.28%
- EPS
- $-5.93 · -213.76%
- Op Income
- $-18,280,000
- FCF YoY
- -376.06%
- 52W High
- $4.61
- 52W Low
- $1.75
- 50D MA
- $3.46
- 200D MA
- $3.18
- Beta
- 1.85
- Avg Volume
- 9.72K
Get TickerSpark's AI analysis on CSCI
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our CSCI coverage
Recent articles, reports, and earnings notes.
No research on CSCI yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CSCI report →Similar companies
Peers in the same neighborhood.